Radiotherapy for metastatic brain tumors.
Radiation therapy has been the most important treatment for patients with brain metastases. With the development of stereotactic irradiation, conventional radiotherapy is being employed less often. However, whole-brain radiation therapy (WBRT) is still the mainstay of treatment for multiple brain metastases. This article reviews the results of conventional radiotherapy for brain metastases, and discusses optimal treatment, including fractionation schedules and combination with stereotactic irradiation, and the effects on neurocognitive functions. The authors conclude that WBRT with 30 Gy in ten fractions is no longer optimal for every patient with multiple brain metastases. WBRT employing appropriate fractionation schedules with or without stereotactic boost should be considered, depending on the patient's condition, disease status, and expected period of life.
Shibamoto
Yuta
Y
Department of Radiology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, Japan. yshiba@med.nagoya-cu.ac.jp
Sugie
Chikao
C
Iwata
Hiromitsu
H
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000556:secondary; D017024:Chemotherapy, Adjuvant; D003072:Cognition Disorders / Q000209:etiology; D016371:Cranial Irradiation / Q000009:adverse effects; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D019583:Dose Fractionation, Radiation; D006801:Humans; D018579:Patient Selection; D011832:Radiation Injuries / Q000209:etiology; D016634:Radiosurgery; D018714:Radiotherapy, Adjuvant; D000077204:Temozolomide; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide
J Clin Oncol. 2002 Aug 15;20(16):3445-53
12177105
Strahlenther Onkol. 1986 Mar;162(3):157-61
3515602
Int J Radiat Oncol Biol Phys. 1992;23(1):229-38
1374064
Clin Oncol (R Coll Radiol). 2001;13(2):105-11
11373870
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):71-8
18164829
Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):75-85
12007944
Radiother Oncol. 1993 Feb;26(2):111-6
7681997
Ann Med. 1998 Jun;30(3):296-9
9677016
Oncology (Williston Park). 2000 Jan;14(1):75-9; discussion 79, 81-2, 85
10680150
Brain Res Mol Brain Res. 1999 Jul 23;71(1):61-8
10407187
Cancer. 1981 Jul 15;48(2):384-94
7237407
Ann Oncol. 2001 Feb;12(2):249-54
11300333
J Neurooncol. 2003 Feb;61(3):203-7
12675312
J Clin Oncol. 2004 Jan 1;22(1):157-65
14701778
Strahlenther Onkol. 1994 Mar;170(3):155-61
8160096
Radiother Oncol. 2008 Mar;86(3):369-74
17881072
J Clin Oncol. 2005 Dec 1;23(34):8870-6
16314647
Cancer Treat Rev. 2005 Jun;31(4):256-73
15951117
J Clin Oncol. 2006 Mar 10;24(8):1295-304
16525185
JAMA. 2006 Jun 7;295(21):2483-91
16757720
Int J Radiat Oncol Biol Phys. 1981 Dec;7(12):1633-8
6174490
Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1311-8
18448270
Technol Cancer Res Treat. 2003 Apr;2(2):111-5
12680791
Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1-9
6154024
Cancer. 1995 Sep 1;76(5):765-73
8625178
Eur J Cancer. 2002 Mar;38(4):487-96
11872340
Expert Opin Pharmacother. 2004 Dec;5(12):2459-67
15571464
J Clin Oncol. 2002 Sep 1;20(17):3644-50
12202665
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):526-32
18474312
Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1484-90
15275736
Cancer. 1954 Jul;7(4):682-9
13172684
J Clin Oncol. 1998 Nov;16(11):3563-9
9817276
Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):333-8
11872278
Pathol Int. 2005 Jun;55(6):303-9
15943786
Eur J Cancer. 1997 Oct;33(11):1752-8
9470828
Int J Radiat Oncol Biol Phys. 1981 Jul;7(7):891-5
6171553
Int J Radiat Oncol Biol Phys. 1977 Nov-Dec;2(11-12):1091-4
74375
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):978-85
17467925
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1168-73
18495375
Curr Opin Neurol. 2003 Apr;16(2):129-34
12644738
J Clin Oncol. 1994 Mar;12(3):627-42
8120563
J Clin Oncol. 2003 Jun 15;21(12):2364-71
12805339
Jpn J Cancer Res. 1986 Sep;77(9):908-15
3095287
Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):571-4
9336134
Neurology. 1989 Jun;39(6):789-96
2725874
J Clin Oncol. 2004 Jun 1;22(11):2101-7
15169796
J Neurooncol. 2001 Jul;53(3):259-65
11718258
Int J Clin Oncol. 2009 Aug;14(4):289-98
19705238
Strahlenther Onkol. 2002 May;178(5):252-8
12082684
Radiology. 1968 Jul;91(1):149-53
4172540
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):971-7
17446005
Technol Cancer Res Treat. 2008 Dec;7(6):417-24
19044320
JAMA. 1998 Nov 4;280(17):1485-9
9809728
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):324-33
17398036